Giving the hepatitis B Vaccine at birth is a routine part of newborn care in the United States. A Big news story recently is that federal guidance has shifted, moving from a universal recommendation to a shared decision-making approach for some infants.
In this episode, I take a neutral, evidence-based look at:
What exactly changed in the Hep B birth dose guidance
What hepatitis B is and why age at infection matters
Why infants and adults respond so differently to the virus
How universal newborn vaccination reduced infections by 99.9%
Where theory and real-world healthcare systems diverge
This discussion avoids politics and focuses on the medicine, the data, and how policy decisions play out in everyday clinical practice.